pDONR223_KRAS_p.G12D Citations (2)

Originally described in: Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.
Kim E, Ilic N, Shrestha Y, Zou L, Kamburov A, Zhu C, Yang X, Lubonja R, Tran N, Nguyen C, Lawrence MS, Piccioni F, Bagul M, Doench JG, Chouinard CR, Wu X, Hogstrom L, Natoli T, Tamayo P, Horn H, Corsello SM, Lage K, Root DE, Subramanian A, Golub TR, Getz G, Boehm JS, Hahn WC Cancer Discov. 2016 Jul;6(7):714-26. doi: 10.1158/2159-8290.CD-16-0160. Epub 2016 May 4. PubMed Journal

---

Articles Citing pDONR223_KRAS_p.G12D

Articles
MET Exon 14 Splice-Site Mutations Preferentially Activate KRAS Signaling to Drive Tumourigenesis. Lu D, Nagelberg A, Chow JL, Chen YT, Michalchuk Q, Somwar R, Lockwood WW. Cancers (Basel). 2022 Mar 8;14(6). pii: cancers14061378. doi: 10.3390/cancers14061378. PubMed
Structural and functional analyses of a germline KRAS T50I mutation provide insights into Raf activation. Chen PY, Huang BJ, Harris M, Boone C, Wang W, Carias H, Mesiona B, Mavrici D, Kohler AC, Bollag G, Zhang C, Zhang Y, Shannon K. JCI Insight. 2023 Sep 8;8(17):e168445. doi: 10.1172/jci.insight.168445. PubMed

If you have published an article using this material, please email us at to have your article added to this page.